# "FDA Regulations & Drug Innovation: An Investor's Perspective" with John Freund, MD, MBA April 03, 2017 ![Freund](/sites/g/files/omnuum9646/files/styles/hwp_1_1__360x360_scale/public/sciencepolicy/files/john08.jpg?itok=f1GONhLD) **WHEN**: Wednesday, April 12, 2:00pm-3:30pm **WHERE**: Goldenson 422 at Harvard Medical School **HOSTED** **BY**: GSAS Science Policy Group RSVP here: This event will be capped at 15 (first to RSVP). We will also have a waitlist. If you RSVP, please do your best to attend! Snacks and drinks will be provided. **SETTING THE SCENE:** So far in this discussion series, we have been fortunate to hear about the fundamentals of drug approval and some concerns regarding changes at the FDA ushered in by the 21st Century Cures Act, but we have yet to hear industry's perspective. During the passage of this new law, there were roughly 1,300 lobbyists in Washington representing drug companies, universities and patient groups, all of which had certain priorities that were sometimes at odds with each other. So what do venture capitalists and drug company executives actually think about FDA policies? Is the FDA too cautious? Does the FDA prevent too many good drugs from getting to patients quickly and cheaply? What does the drug industry want in a new FDA commissioner? Are they pleased or concerned about the massive deregulation promised by the new administration? Is the popular criticism of the drug industry justified? Join us and our guest John Freund, MD, MBA for a lively discussion on these issues! **BACKGROUND ON OUR GUEST:** Dr. Freund graduated from HMS with his MD in 1980 and got his MBA from HBS before going to work in venture capital. Since then, Dr. Freund has invested in dozens of successful drug companies, has sat on many boards and has helped to develop countless innovative drugs. Dr. Freund has an incredible command of many topics related to the history of drug development as well as an unmatched business acumen. Currently, Dr. Freund is the Founder and Managing Director at Skyline Ventures in Palo Alto, CA. Contact Cory Gerlach (​) with any questions. Share on:- [ Facebook ](#) - [ Twitter ](#) - [ Linkedin ](#)